1. Home
  2. GLP vs TRAX Comparison

GLP vs TRAX Comparison

Compare GLP & TRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Partners LP

GLP

Global Partners LP

N/A

Current Price

$44.18

Market Cap

1.8B

Sector

Energy

ML Signal

N/A

TRAX

First Tracks Biotherapeutics Inc. Ordinary Shares

N/A

Current Price

$47.60

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GLP
TRAX
Founded
2005
2025
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
2005
2026

Fundamental Metrics

Financial Performance
Metric
GLP
TRAX
Price
$44.18
$47.60
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
★ $75.17
AVG Volume (30 Days)
69.2K
★ 716.3K
Earning Date
11-06-2026
11-03-2026
Dividend Yield
★ 7.18%
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $18,561,421,000.00
N/A
Revenue This Year
$43.70
N/A
Revenue Next Year
$25.83
N/A
P/E Ratio
$23.28
★ N/A
Revenue Growth
★ 8.14
N/A
52 Week Low
$39.58
$15.69
52 Week High
$54.29
$54.78

Technical Indicators

Market Signals
Indicator
GLP
TRAX
Relative Strength Index (RSI) 43.06 58.17
Support Level $41.32 $35.11
Resistance Level $49.74 $48.94
Average True Range (ATR) 1.82 3.20
MACD -0.12 0.15
Stochastic Oscillator 42.06 39.33

Price Performance

Historical Comparison
GLP
TRAX

About GLP Global Partners LP

Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the GDSO segment.

About TRAX First Tracks Biotherapeutics Inc. Ordinary Shares

First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter, for which it completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a BDCA2 modulator, in a Phase 1a trial. The company operates in one reportable segment focused on research and development activities to deliver immunology therapeutics for autoimmune and inflammatory diseases.

Share on Social Networks: